top of page


AGC Biologics expands dual-site pharmaceutical manufacturing contract to more than €500 million
AGC Biologics has expanded a long-term manufacturing agreement with an unnamed global pharmaceutical company to more than €500 million, adding six commercial biologics programmes at its Copenhagen facility.

nuaxia
Nov 42 min read


Alvotech and LOTTE Biologics sign US manufacturing partnership for multiple biosimilars
Alvotech and LOTTE Biologics have entered a US manufacturing agreement covering multiple antibody biosimilars for global supply.

nuaxia
Oct 71 min read
bottom of page